Chiracon Overview

  • Founded
  • 1998
  • Status
  • Private
  • Employees
  • 14
  • Latest Deal Type
  • 2ndary - Private

Chiracon General Information


Developer of drug synthesis and documentation intended to offer all services possible in the field of synthetic drug development for new or generic products. The company's drug synthesis and documentation are developed with the help of chemicals such as amino acids, amines, heptahelicene and organic compounds, along with offering chiral building blocks for technical applications, enabling the pharmaceutical sector to get innovative intermediary manufacturing processes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Specialty Chemicals
Primary Office
  • Biotechnologie Park
  • 14943 Luckenwalde
  • Germany
+49 03371 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Chiracon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Jan-2008 Completed Generating Revenue
2. Later Stage VC 01-Apr-2005 Completed Generating Revenue
1. Early Stage VC 04-Jul-2002 Completed Startup
To view Chiracon’s complete valuation and funding history, request access »

Chiracon Executive Team (3)

Name Title Board Seat Contact Info
Ralf Zuhse Founder, Owner & Managing Director
Anne Hermeneit Head, Sales & Marketing
You’re viewing 2 of 3 executive team members. Get the full list »

Chiracon Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial